ASTH - CIK 0001083446
The table below shows Astrana Health, Inc.'s cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|---|---|
| Operating cash flow | $68.06M | $16.63M | $5.98M | $7.72M | $24.04M | $9.95M |
| Capital expenditure | $4.00M | $3.07M | $369.00K | $6.03M | $17.49M | $98.00K |
| Investing cash flow | -$2.84M | -$2.39M | -$71.04M | -$14.04M | -$19.73M | $692.00K |
| Dividends paid | - | - | - | $120.00K | $1.18M |
Astrana Health, Inc. reported operating cash flow of $114.60M for fiscal year 2025. That is up 119.5% from $52.20M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow grew from $21.91M (FY 2016) to $114.60M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $4.00K |
| Stock buybacks | $2.80M | $10.60M | - | $0.00 | $230.00K | $342.00K |
| Financing cash flow | -$15.96M | -$44.17M | $106.35M | -$7.10M | $532.00K | $1.26M |